A later study showed the similar prognostic significance of the ratio of TIA-1+/CD8+ T-cells to FoxP3+ Treg cells in a cohort of RR cHL patients [76], which was similar to the findings in a study on follicular B-cell lymphoma [77]. The gene discussed is CD8A; the disease is classic Hodgkin lymphoma.